Iceland· IS-IS/1/23/087/01

Neiratax

A vitamin b1 in combination with vitamin b6 and/or vitamin b12 product containing lidocainum inn hýdróklóríð,thiaminum inn hýdróklóríð,cyanocobalaminum inn,pyridoxinum inn hýdróklóríð, registered in Iceland by Kalceks AS. The same ATC class is registered in 7 of our 19 countries.

ATC A11DB

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedNeirataxATCA11DBREGISTER NO.IS-IS/1/23/087/01PACKS LISTED0CHECKEDSeptember 29, 2026

Where it is registered

Lidocainum inn hýdróklóríð,thiaminum inn hýdróklóríð,cyanocobalaminum inn,pyridoxinum inn hýdróklóríð is registered in 7 of 19 countries.

Countries holding a registration under ATC A11DB (vitamin b1 in combination with vitamin b6 and/or vitamin b12), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 7 of them publish a price we can compare per daily dose

Lidocainum inn hýdróklóríð,thiaminum inn hýdróklóríð,cyanocobalaminum inn,pyridoxinum inn hýdróklóríð · ATC A11DB

7 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Icelandprice
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Lidocainum INN hýdróklóríð,Thiaminum INN hýdróklóríð,Cyanocobalaminum INN,Pyridoxinum INN hýdróklóríð
Manufacturer
Kalceks AS
Country
Iceland (IS)
ATC code
A11DB
ATC class
Vitamin B1 in combination with vitamin B6 and/or vitamin B12
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lidocainum inn hýdróklóríð,thiaminum inn hýdróklóríð,cyanocobalaminum inn,pyridoxinum inn hýdróklóríð in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lidocainum inn hýdróklóríð,thiaminum inn hýdróklóríð,cyanocobalaminum inn,pyridoxinum inn hýdróklóríð products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Bulgaria · Бетагамма, Милгамма N, Milgamma N
  • Czechia · Milgamma N
  • Estonia · Milgamma N, Neiratax
  • Lithuania · Neiratax
  • Latvia · Neiratax
  • Poland · Neiraxin B
  • Romania · Neiraxin
  • Slovakia · Milgamma N

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/580f2d22-2e6d-4847-9944-4361606d00a8
GET /v1/drugs/580f2d22-2e6d-4847-9944-4361606d00a8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Stungulyf, lausn",
  "source": "lyfjastofnun",
  "atc_raw": "A11DB",
  "marketed": false,
  "strength": "100 mg/100 mg/1 mg/20 mg/2 ml",
  "ma_number": "IS/1/23/087/01",
  "substance": "Lidocainum INN hýdróklóríð,Thiaminum INN hýdróklóríð,Cyanocobalaminum INN,Pyridoxinum INN hýdróklóríð",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt",
  "ma_issued_serial": "45160"
}

See everything about lidocainum inn hýdróklóríð,thiaminum inn hýdróklóríð,cyanocobalaminum inn,pyridoxinum inn hýdróklóríð.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.